LOS ANGELES--(BUSINESS WIRE)--CytoDyn, Inc. (Pink Sheets: CYDY) is featured in a documentary about its lead product Cytolin®, the first immune based drug for HIV/AIDS that has been successfully used in about 200 patients to prevent the human immune system from self-destructing in response to HIV infection. This story was previously reported by Dr. Cynthia Allison in an investigative series from CBS TV News. The new documentary tracks the Company’s steady progress despite the fact that it usually takes 20 years and some very tenacious researchers to bring a new drug to market, even when experts know the drug will save lives. Examples of the latter include the history of two oncology drugs, in the same class as Cytolin®, that are now mainstream cancer treatments: Avastin® from Genentech (EBS: DNA) and Erbitux® from Imclone (NasdaqGS: IMCL).
